Cancer treatment-associated hypomagnesemia: Analysis from a large pharmacovigilance database.
作者信息
Klomjit Nattawat, Evans Richard, Sise Meghan E, Jhaveri Kenar D, Gupta Shruti
机构信息
Division of Nephrology and Hypertension, Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
出版信息
Eur J Intern Med. 2025 Jun 30. doi: 10.1016/j.ejim.2025.06.012.
Abstract
摘要
相似文献
1
Cancer treatment-associated hypomagnesemia: Analysis from a large pharmacovigilance database.
Eur J Intern Med. 2025 Jun 30. doi: 10.1016/j.ejim.2025.06.012.
2
Immune checkpoint inhibitor-associated myocarditis and pericarditis: a pharmacovigilance study based on the FAERS database.
BMC Cancer. 2025 Aug 9;25(1):1294. doi: 10.1186/s12885-025-14668-x.
3
Interstitial lung disease induced by fluoxetine: Systematic review of literature and analysis of Vigiaccess, Eudravigilance and a national pharmacovigilance database.
Pharmacol Res. 2017 Jun;120:294-301. doi: 10.1016/j.phrs.2017.04.010. Epub 2017 Apr 12.
4
Sex differences in drug-induced osteoporosis: a pharmacovigilance study based on the FAERS database.
Front Public Health. 2025 Jul 24;13:1630412. doi: 10.3389/fpubh.2025.1630412. eCollection 2025.
5
Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.
Ther Adv Drug Saf. 2025 Jun 11;16:20420986241300006. doi: 10.1177/20420986241300006. eCollection 2025.
6
Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.
Endocr Res. 2016 May;41(2):142-7. doi: 10.3109/07435800.2015.1094088. Epub 2016 Mar 2.
7
Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies.
Ren Fail. 2015 Aug;37(7):1237-41. doi: 10.3109/0886022X.2015.1057800. Epub 2015 Jun 25.
8
The relationship between hypomagnesemia and ICU mortality in severe hemorrhagic stroke patients: an observational multicentre study on eICU database.
BMC Cardiovasc Disord. 2025 Feb 1;25(1):73. doi: 10.1186/s12872-025-04525-x.
9
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system.
Front Immunol. 2024 Apr 30;15:1396752. doi: 10.3389/fimmu.2024.1396752. eCollection 2024.
10
Post-marketing safety analysis of blonanserin: a retrospective pharmacovigilance study using the Japanese adverse drug event report database (2008-2024).
Eur J Pharmacol. 2025 Sep 15;1003:177933. doi: 10.1016/j.ejphar.2025.177933. Epub 2025 Jul 10.
本文引用的文献
1
Frequency and characteristics of chemotherapy-associated thrombotic microangiopathy: Analysis from a large pharmacovigilance database.
Am J Hematol. 2023 Dec;98(12):E369-E372. doi: 10.1002/ajh.27101. Epub 2023 Sep 23.
2
Hypomagnesemia in Patients With Cancer: The Forgotten Ion.
Semin Nephrol. 2022 Nov;42(6):151347. doi: 10.1016/j.semnephrol.2023.151347. Epub 2023 Apr 21.
3
Hypomagnesemia in the Cancer Patient.
Kidney360. 2020 Nov 11;2(1):154-166. doi: 10.34067/KID.0005622020. eCollection 2021 Jan 28.
4
Specific disruption of calcineurin-signaling in the distal convoluted tubule impacts the transcriptome and proteome, and causes hypomagnesemia and metabolic acidosis.
Kidney Int. 2021 Oct;100(4):850-869. doi: 10.1016/j.kint.2021.06.030. Epub 2021 Jul 10.
5
Pathophysiology of Drug-Induced Hypomagnesaemia.
Drug Saf. 2020 Sep;43(9):867-880. doi: 10.1007/s40264-020-00947-y.
6
Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors.
Front Oncol. 2019 Sep 20;9:849. doi: 10.3389/fonc.2019.00849. eCollection 2019.
7
Adverse kidney effects of epidermal growth factor receptor inhibitors.
Nephrol Dial Transplant. 2017 Jul 1;32(7):1089-1097. doi: 10.1093/ndt/gfw467.
8
The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity.
PLoS One. 2013;8(2):e57016. doi: 10.1371/journal.pone.0057016. Epub 2013 Feb 15.
9
The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.
Drug Saf. 1998 Jul;19(1):1-10. doi: 10.2165/00002018-199819010-00001.
Zotero 插件